Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Invested Capital (2020 - 2025)

Historic Invested Capital for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to $77.3 million.

  • NeuroPace's Invested Capital rose 1183.55% to $77.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $77.3 million, marking a year-over-year increase of 1183.55%. This contributed to the annual value of $67.5 million for FY2024, which is 1297.55% down from last year.
  • Latest data reveals that NeuroPace reported Invested Capital of $77.3 million as of Q3 2025, which was up 1183.55% from $78.1 million recorded in Q2 2025.
  • NeuroPace's 5-year Invested Capital high stood at $138.0 million for Q2 2021, and its period low was -$107.4 million during Q1 2021.
  • In the last 5 years, NeuroPace's Invested Capital had a median value of $78.1 million in 2025 and averaged $79.5 million.
  • Examining YoY changes over the last 5 years, NeuroPace's Invested Capital showed a top increase of 20518.29% in 2022 and a maximum decrease of 2890.96% in 2022.
  • Over the past 5 years, NeuroPace's Invested Capital (Quarter) stood at $123.4 million in 2021, then fell by 28.91% to $87.7 million in 2022, then decreased by 11.5% to $77.6 million in 2023, then fell by 12.98% to $67.5 million in 2024, then rose by 14.4% to $77.3 million in 2025.
  • Its last three reported values are $77.3 million in Q3 2025, $78.1 million for Q2 2025, and $84.1 million during Q1 2025.